Good
Start Genetics®, Inc., a commercial-stage molecular
genetic information company that has designed a proprietary technology
platform to harness the power of next-generation DNA sequencing (NGS) to
detect mutations that cause inherited genetic disorders, today announced
the appointment of Charles F. Wagner, Jr. to the company’s board of
directors.
“Charlie’s strong financial, management and operational experience
within the life sciences industry will add a valuable perspective to our
board of directors,” stated Don Hardison, president and chief executive
officer of Good Start Genetics. “We look forward to benefiting from
Charlie’s insights as we continue to provide physicians and their
patients with clinically relevant and actionable information concerning
inherited genetic disorders.”
Mr. Wagner is currently chief financial officer and executive vice
president, finance and administration of Bruker Corporation (NASDAQ:
BRKR), a global leader in analytical instrumentation and related
solutions for life science, material science and applied markets. Prior
to Bruker, Mr. Wagner served as chief financial officer and executive
vice president, finance and administration of Progress Software
Corporation (NASDAQ: PRGS), a provider of enterprise software located in
Bedford, Mass. Earlier, Mr. Wagner served as chief financial officer and
vice president of Millipore Corporation, a global provider of products
and services in the life science tools market until it was acquired by
Merck KGaA in July 2010. Mr. Wagner successfully managed all financial
and operational aspects of the sale of Millipore to Merck KGaA, a
transaction valued at nearly $7 billion. Prior to his full time
employment at Bruker, Mr. Wagner served on the board of directors and as
a member of the audit committee at Bruker and also served as a director
of Bruker Energy & Supercon Technologies, Inc., a subsidiary of Bruker,
where he was a member of the audit committee. Mr. Wagner holds a B.S.
from Boston College and an MBA from Harvard University Graduate School
of Business Administration.
“Good Start Genetics is seeking to set a new standard of care for
genetic screening of inherited diseases,” said Mr. Wagner. “I am
thrilled to be joining the Good Start Genetics team as they continue to
deliver superior genetic carrier screening test offerings and expand in
the reproductive medicine field.”
About GoodStart Select™
GoodStart Select is Good Start Genetics’ menu of genetic carrier
screening tests that, for diseases such as cystic fibrosis, detects many
more disease-causing mutations than traditional genotyping-based
screening tests, regardless of patient ethnicity. The product of years
of development and rigorous validation, GoodStart Select includes
a suite of proprietary technologies, processes and algorithms designed
to harness the power of next-generation DNA sequencing (NGS), to provide
highly accurate and actionable tests resulting in higher mutation
detection rates and fewer missed carriers.
To support its genetic carrier screening capabilities, Good Start
Genetics has a dedicated team of customer care specialists and board
certified genetic counselors who provide step-by-step support, from test
selection through results, analysis and reporting. Good Start Genetics
seeks to enable reproductive health specialists and their patients to
have the highest degree of confidence in their genetic carrier screening
results.
About
Good Start Genetics, Inc.
Good Start Genetics is a commercial-stage molecular genetic information
company focused on fundamentally transforming the standard of care in
reproductive medicine by providing physicians and their patients with
clinically relevant and actionable information concerning inherited
genetic disorders. Good Start Genetics’ powerful, proprietary
next-generation DNA sequencing (NGS) capabilities are supplemented by
other proven genetic screening technologies and supported by its
commitment to customer care and genetic counseling. Through GoodStart
Select, the company provides a comprehensive and clinically
actionable menu of genetic carrier screening tests for known and novel
mutations that cause inherited genetic disorders. For more information,
please visit www.goodstartgenetics.com.
Copyright Business Wire 2014